• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有常见疾病但低多基因风险评分的个体可优先进行罕见变异筛查。

Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening.

机构信息

Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.

Quantitative Life Sciences Program, McGill University, Montreal, QC, Canada.

出版信息

Genet Med. 2021 Mar;23(3):508-515. doi: 10.1038/s41436-020-01007-7. Epub 2020 Oct 28.

DOI:10.1038/s41436-020-01007-7
PMID:33110269
Abstract

PURPOSE

Identifying rare genetic causes of common diseases can improve diagnostic and treatment strategies, but incurs high costs. We tested whether individuals with common disease and low polygenic risk score (PRS) for that disease generated from less expensive genome-wide genotyping data are more likely to carry rare pathogenic variants.

METHODS

We identified patients with one of five common complex diseases among 44,550 individuals who underwent exome sequencing in the UK Biobank. We derived PRS for these five diseases, and identified pathogenic rare variant heterozygotes. We tested whether individuals with disease and low PRS were more likely to carry rare pathogenic variants.

RESULTS

While rare pathogenic variants conferred, at most, 5.18-fold (95% confidence interval [CI]: 2.32-10.13) increased odds of disease, a standard deviation increase in PRS, at most, increased the odds of disease by 5.25-fold (95% CI: 5.06-5.45). Among diseased patients, a standard deviation decrease in the PRS was associated with, at most, 2.82-fold (95% CI: 1.14-7.46) increased odds of identifying rare variant heterozygotes.

CONCLUSION

Rare pathogenic variants were more prevalent among affected patients with a low PRS. Therefore, prioritizing individuals for sequencing who have disease but low PRS may increase the yield of sequencing studies to identify rare variant heterozygotes.

摘要

目的

确定常见疾病的罕见遗传病因可以改善诊断和治疗策略,但成本高昂。我们测试了是否患有常见疾病且该疾病的低多基因风险评分(PRS)来自成本较低的全基因组基因分型数据的个体更有可能携带罕见的致病性变异。

方法

我们在 UK Biobank 中对 44550 名接受外显子组测序的个体中,鉴定出患有五种常见复杂疾病之一的患者。我们为这五种疾病推导了 PRS,并确定了致病性罕见变异杂合子。我们测试了患有疾病且 PRS 较低的个体是否更有可能携带罕见的致病性变异。

结果

虽然罕见的致病性变异最多可将疾病的几率增加 5.18 倍(95%置信区间[CI]:2.32-10.13),但 PRS 的标准偏差增加最多可将疾病的几率增加 5.25 倍(95% CI:5.06-5.45)。在患病患者中,PRS 的标准偏差降低最多可使罕见变异杂合子的几率增加 2.82 倍(95% CI:1.14-7.46)。

结论

低 PRS 的患病患者中更常见罕见的致病性变异。因此,优先对患有疾病但 PRS 较低的个体进行测序可能会增加测序研究以识别罕见变异杂合子的产量。

相似文献

1
Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening.具有常见疾病但低多基因风险评分的个体可优先进行罕见变异筛查。
Genet Med. 2021 Mar;23(3):508-515. doi: 10.1038/s41436-020-01007-7. Epub 2020 Oct 28.
2
Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases.多基因风险评分作为一种可能的工具,用于识别复杂疾病的家族性单基因病因。
Genet Med. 2022 Jul;24(7):1545-1555. doi: 10.1016/j.gim.2022.03.022. Epub 2022 Apr 23.
3
Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.基于人群的前瞻性队列研究:东亚常见癌症的多基因风险评分预测。
Elife. 2023 Mar 27;12:e82608. doi: 10.7554/eLife.82608.
4
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.常见遗传变异对疾病家族聚集性的贡献及其对测序研究的意义。
PLoS Genet. 2019 Nov 15;15(11):e1008490. doi: 10.1371/journal.pgen.1008490. eCollection 2019 Nov.
5
Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers.多基因风险和罕见变异基因聚类增强了乳腺癌和前列腺癌的风险分层。
Commun Biol. 2024 Oct 9;7(1):1289. doi: 10.1038/s42003-024-06995-9.
6
Gene-based burden scores identify rare variant associations for 28 blood biomarkers.基于基因的负担评分可识别 28 种血液生物标志物的罕见变异关联。
BMC Genom Data. 2023 Sep 4;24(1):50. doi: 10.1186/s12863-023-01155-0.
7
Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India.全基因组多基因风险评分可预测印度单基因未确诊早发性帕金森病患者中的大量高危个体。
Adv Biol (Weinh). 2022 Nov;6(11):e2101326. doi: 10.1002/adbi.202101326. Epub 2022 Jul 10.
8
Polygenic burden in focal and generalized epilepsies.多基因负担在局灶性和全面性癫痫中的作用。
Brain. 2019 Nov 1;142(11):3473-3481. doi: 10.1093/brain/awz292.
9
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.全基因组建模分析多基因风险评分在结直肠癌风险中的作用。
Am J Hum Genet. 2020 Sep 3;107(3):432-444. doi: 10.1016/j.ajhg.2020.07.006. Epub 2020 Aug 5.
10
Monogenic and Polygenic Contributions to QTc Prolongation in the Population.单基因和多基因对人群 QTc 延长的贡献。
Circulation. 2022 May 17;145(20):1524-1533. doi: 10.1161/CIRCULATIONAHA.121.057261. Epub 2022 Apr 7.

引用本文的文献

1
Improving polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features.通过利用预测的表观基因组特征提高全基因组测序数据的多基因预测能力。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2419202122. doi: 10.1073/pnas.2419202122. Epub 2025 Jun 12.
2
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation.特发性肺纤维化患者的罕见变异与生存情况:一项多中心观察性队列研究及独立验证分析
Lancet Respir Med. 2025 Jun;13(6):495-504. doi: 10.1016/S2213-2600(25)00045-1. Epub 2025 Apr 28.
3
Utility of Polygenic Risk Scores (PRSs) in Predicting Pancreatic Cancer: A Systematic Review and Meta-Analysis of Common-Variant and Mixed Scores with Insights into Rare Variant Analysis.
多基因风险评分(PRSs)在预测胰腺癌中的效用:对常见变异和混合评分的系统评价与荟萃分析,并对罕见变异分析有所洞察
Cancers (Basel). 2025 Jan 13;17(2):241. doi: 10.3390/cancers17020241.
4
Oligogenic risk score for Gilles de la Tourette syndrome reveals a genetic continuum of tic disorders.抽动秽语综合征的寡基因风险评分揭示了抽动障碍的遗传连续性。
J Appl Genet. 2025 Jan 10. doi: 10.1007/s13353-024-00930-8.
5
interference leading to erroneous identification of a pathogenic variant in Black patients.干扰导致黑人患者中致病变异的错误识别。
Genet Med Open. 2024 Jun 10;2:101858. doi: 10.1016/j.gimo.2024.101858. eCollection 2024.
6
Rare variants and survival of patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的罕见变异与生存情况
medRxiv. 2024 Oct 15:2024.10.12.24315151. doi: 10.1101/2024.10.12.24315151.
7
Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers.多基因风险和罕见变异基因聚类增强了乳腺癌和前列腺癌的风险分层。
Commun Biol. 2024 Oct 9;7(1):1289. doi: 10.1038/s42003-024-06995-9.
8
Polygenic embryo screening: quo vadis?多基因胚胎筛查:路在何方?
J Assist Reprod Genet. 2024 Jul;41(7):1719-1726. doi: 10.1007/s10815-024-03169-8. Epub 2024 Jun 15.
9
Genetic modifiers of rare variants in monogenic developmental disorder loci.单基因发育障碍基因座中罕见变异的遗传修饰物。
Nat Genet. 2024 May;56(5):861-868. doi: 10.1038/s41588-024-01710-0. Epub 2024 Apr 18.
10
Genetic Evaluation for Monogenic Disorders of Low Bone Mass and Increased Bone Fragility: What Clinicians Need to Know.单基因低骨量和骨脆性增加疾病的遗传评估:临床医生需要了解的内容。
Curr Osteoporos Rep. 2024 Jun;22(3):308-317. doi: 10.1007/s11914-024-00870-6. Epub 2024 Apr 11.